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Condensation 
 
This epidemiological study reports significant seasonal trends with peaks in August in 
mortality in female genital organs and breast cancer. 
 
 
  
Trends in mortality rates in female genital organs and breast cancers in Hungary 
between 1979 and 2013 
Margit Hartai, Tibor András Nyári, Richard J.Q, McNally 
Abstract 
Objective: This study investigated annual and seasonal trends in deaths for cancers of the 
female genital organs and breast in Hungary between 1979 and 2013. 
Study Design: Data on the numbers of cancer deaths were obtained from the published 
nationwide population register. Joinpoint regression was applied to investigate the yearly trends 
in cancer mortality rates. Cyclic trends were investigated using logistic regression, Edwards’ 
and Walter-Elwood methods. 
Results: The majority of deaths from cancers of the female genital organs and breast occurred 
in winter but using the observed numbers of deaths a significant seasonal pattern was only 
revealed for deaths from breast cancer with a peak in January and a nadir in July. However, 
seasonality in the proportion of deaths from female genital organs and breast cancers out of 
deaths from all causes detected a different peak and nadir. The proportion of female genital 
organs and breast cancer deaths out of deaths from all causes was higher around the end of 
summer and significant seasonal variation with a peak in August and nadir in February was 
revealed.  
Conclusion: This Hungarian study suggests that there was a significant seasonal effect on 
female genital organs and breast cancer mortality. Both seasonal patterns are interesting and 
informative to potentiate prevention. Our findings suggest that infectious diseases may increase 
the risk of the mortality among the immune deficient patents. 
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 Introduction 
Breast and cervical cancers are both common malignancies in Hungarian women. In Hungary, 
annually approximately 5500 and 1200 new cases are diagnosed with breast and cervical cancer, 
respectively [1]. Furthermore, the mortality rate of breast cancer is high in Hungary as the vast 
proportion of these cases are diagnosed too late [2-3]. Similarly, mortality rates for corpus uteri 
and ovarian cancers are in a higher rank than in the other countries of the European Union [4]. 
The susceptibility to an infectious disease is higher among cancer patients as their immune 
system is suppressed. If seasonal variation in the onset of disease could be shown in any of the 
diagnostic subgroups, this could be interpreted as supportive evidence for an etiology linked to 
exposure to infection [5]. 
In this study, together with analyses of changes in mortality rates for malignant neoplasms of 
female genital organs and breast, the annual and seasonal trends in mortality rates are 
investigated in Hungary between 1979 and 2013. 
 
Material and methods 
Study population  
The 35-year period between 1979 and 2013 was considered in this analysis. Data on the 
population and numbers of deaths from malignant neoplasms of female genital organs and 
breast were obtained from the published nationwide population register of the Hungarian 
Central Statistical Office [6]. 
The data concerning cause of deaths were published annually by the Central Statistical Office. 
These data were classified according to the ICD10 codes. The main categories were: malignant 
neoplasms of breast (ICD10: C50), malignant neoplasm of cervix uteri (ICD10:C53), malignant 
neoplasm of uterus: corpus uteri (ICD10:C54) part unspecified (ICD10:C55) and malignant 
neoplasm of ovary (ICD10:C56). Data on both the population and numbers of deaths from 
cancer were classified by age groups as follow: 0-14 years, 15-39 years, 40-59 years, 60-69 
years, 70-79 years and over 80 years. Thus, age-specific death rates were calculated. 
Furthermore, the mortality rates of cancer of the female genital organs and breast were directly 
standardized using the standard world population to make comparisons easier. Since the 
numbers of deaths were too small in the group aged 0-14 years, all analyses were carried out 
omitting this group. There were no data on malignant neoplasm of vulva (ICD10:C51), vagina 
(ICD10:C52), placenta (ICD10:C58) and other and unspecified female genital organs 
(ICD10:C57). 
 
Investigation of seasonal trends  
The numbers of monthly deaths from cancers of the female genital organs and breast have been 
available since 1979 [6]. Also data on the total numbers of monthly deaths from all causes were 
available for each year of the study period and were obtained from the published nationwide 
population register. Although the ICD coding underwent change, data on deaths from cancer of 
the female genital organs and breast were consistently available during the study period. 
 
Statistical methods 
Investigation of annual trend 
Age-standardized mortality rates (ASMRs) were used to investigate trends in mortality rates 
for malignant neoplasms of the female genital organs and breast in Hungary.  
Trends were investigated using negative binomial regression models in analyses by age group 
for cancers of the female genital organs and breast. Relative risks (RR) and 95% confidence 
intervals (95% CIs) were calculated. Joinpoint regression analyses were additionally applied to 
characterize trends and to find turning points during the period 1979-2013. Joinpoint analyses 
were done using the joinpoint regression software (version 4.0.4) obtained from the 
Surveillance Research Program of the US National Cancer Institute [7] 
 
Investigation of seasonal trends  
Data on the month of the death were aggregated over the study period. Cyclical trends in these 
monthly data were investigated using the Edwards’ test [8], the Walter-Elwood method [9] and 
the logistic regression method [5] using both sine and cosine functions. Monthly cyclical trends 
(seasonality) were investigated in the following groups: deaths from malignant neoplasms of 
the breast, cervix uteri, uterus and ovary, respectively.  
P-values less than 0.05 were considered to be statistically significant. All analyses were 
performed using STATA Software version 12.0 (Stata Corp LP, College Station, Texas, USA) 
 
 
Results 
Overall, there were 74 920, 18 610, 22 885 and 19 472 deaths from breast cancer, cervix cancer, 
corpus uteri cancer and ovarian cancer, respectively, in Hungary during the period 1979-2013. 
Most deaths occurred from breast cancer (Table 1). The crude mortality rates were 39.661 per 
100 000 persons per year, 9.916 per 100 000 persons per year, 12.193 per 100 000 persons per 
year and 10.291 per 100 000 persons per year for breast cancer, cervix cancer, corpus uteri 
cancer and ovarian cancer. After direct standardization these rates became 24.254 per 100 000 
persons per year, 6.893 per 100 000 persons per year, 7.449 per 100 000 persons per year and 
5.721 per 100 000 persons per year for breast cancer, cervix cancer, corpus uteri cancer and 
ovarian cancer. 
The smallest age-standardized mortality rates for malignant neoplasms of the female genital 
organs and breast were observed in Hungary in 2009. Annual age-standardized mortality rates 
between 19.557 per 100 000 persons per year (2009) and 27.751 per 100 000 persons per year 
(1994) were observed in breast cancer mortality (Figure 1). For malignant neoplasms of the female 
genital organs the annual ASMRs varied between 4.553 per 100 000 persons per year (2009) and 
9.332 per 100 000 persons per year (1982) in cervix cancer mortality, between 9.571 per 100 000 
persons per year (1979) and 2.961 per 100 000 persons per year (2009) in corpus uteri cancer 
mortality and between 8.905 per 100 000 persons per year (1980), and 6.113 per 100 000 
persons per year (1979) in ovarian cancer mortality(Figure 1). 
Although the highest age-specific mortality rates were observed in the group aged over 80 
years, however, after standardization the highest ASMRs were observed in the group aged 40-
59 years (Table 2). The ASMRs decreased in the older age groups for all malignant neoplasms 
of the female genital organs and breast. 
 
Annual trends in mortality 
The negative binomial regression model for annual age-standardized data revealed a declining 
trend in the l yearly ASMRs for cervical cancer (RR 0.981 95%CI [0.968-0.993]; p= 0.003) and 
corpus uteri cancer (RR: 0.968, 95% CI[0.954-0.981] p< 0.001) during the study period but no 
linear trend was found for breast cancer and ovarian cancer mortality. 
Similarly, decreasing annual trends in the ASMRs of cervical cancer and corpus uteri cancer 
(Figure 1b) were found using joinpoint regression during the study period. However, a slightly 
increasing trend in the ASMRs of corpus uteri cancer was detected (Figure 1c).  
The joinpoint analyses depicted turning points in 1998 and 2009 for breast cancer mortality and 
changes in segmented linear trends (Figure 1a-1d). The annual changes in percentages and 
slopes of the segments in the deaths from breast cancer for 1979–1998 were: 0.89 % (p=0.001), 
for 1998–2009: -2.8 % (p=0.001) and for 2009–2013: 1.1 % (p = 0.08). 
The annual changes in percentages and slopes of the segments in the deaths from ovarian cancer 
for 1979–2009 were: 0.9 % (p<0.001) and for 2009–2013: 3.8 % (p=0.072). 
 
Seasonal trends 
The aggregated numbers of deaths are summarized in Table 3. The overall proportion of the 
deaths from breast cancer was the highest among all deaths (Table 3). Using the Edwards’ 
method, a significant cyclic trend was found in the monthly deaths from breast cancer and 
ovarian cancer. The significant peaks were in January and in September for breast cancer and 
ovarian cancer, respectively. Furthermore, significant seasonality was detected for all deaths 
using Edwards’ method with a peak in January and a nadir in July (Figure 2).  
However, applying the Walter-Elwood method which took into account the number of all deaths 
as the underlying population, a different pattern of significant seasonal variation was observed 
in all cancer groups with a peak in August and a nadir in February (Figure 3a-d.). 
The logistic regression method revealed similar seasonal trends as the Walter-Elwood method  
for each cancer group. There was no significant double peak model of seasonality. 
 
 
Discussion 
Main findings 
Decreasing annual trends in the ASMRs of cervical cancer and corpus uteri cancer were found 
during the study period.  
In contrast to Nakaji et al [10], significant seasonality was detected for overall deaths using 
Edward’s method with a peak in January and a nadir in July. Since the largest observed numbers 
of deaths were in the winter months, thus it could reflect the seasonality of infectious diseases 
in temperate climates: respiratory virus infections (for example, influenza, parainfluenza, etc.) 
show marked seasonality occurring in the winter months [11]. 
Similarly, the majority of deaths from cancers of female genital organs occurred in winter but 
a significant seasonal pattern was only revealed for deaths from breast cancer with a peak in 
January and a nadir in July using the observed numbers of deaths.  
However, seasonality in the proportion of deaths from female genital organs and breast cancers 
detected a different peak and nadir. Since the proportion of female genital organs and breast 
cancer deaths among all deaths was higher around the end of summer the Walter-Elwood and 
logistic regression methods showed significant seasonal variation with a peak in August and 
nadir in February. Thus, both seasonal patterns (deaths from cancers of female genital organs 
and deaths from all causes) are interesting and informative to potentiate prevention.  
As far as we are aware, this is the first epidemiological study reporting the effect of seasonality 
for deaths from female genital organs and breast cancers.   
 
Strength and weaknesses 
The data were obtained from civil registers, which could have been influenced by a certain 
simplification (e.g. lack of subtype of cause of death) of categorization during the 35-year 
interval of the study.  
The description of incidence rates in terms of seasonal variations or cyclic trends is important 
in many epidemiological studies. Both the Edwards and the Walter-Elwood methods are 
statistical tests to detect seasonality. However, the Edwards method does not use the population 
at risk only observed frequencies of deaths were used. Furthermore, the logistic regression 
method using both sine and cosine functions was applied to model seasonality. These functions 
can be incorporated in a regression model which allows the investigation of single or double 
peaks of seasonality. Although the underlying infectious agents are unknown, an investigation 
of seasonality stands as an important component in the understanding of the etiological 
description of certain diseases. 
 
Comparison with other studies 
Many studies have reported investigations of trends in cancer incidence and mortality in 
different geographical areas [12-15]. Hungarian mortality rates in breast cancer (20.7 per 100 
000 persons per year), uterus cancer (3.75 per 100 000 persons pear year) and ovarian cancer 
(7.02 per 100 000 persons per year) were higher in 2012 than mortality rates in Central Europe 
as reported by Ferlay et al: mortality rates for breast cancer, cervical cancer, uterus cancer and 
ovarian cancer in 2012 were 16.5, 6.5, 3.4 and 6.0 per 100 000 persons per year, respectively 
[15]. However, the mortality rate in cervical cancer (5.22 per 100 000 persons per year) was 
smaller in Hungary than the Central European mortality rate [16]. Similar to Minelli et al, 
decreasing trends in mortality rates were found for malignant neoplasms of female cervical and 
uterus cancers in Hungary between 1979 and 2013 [17]. 
In our study, trends in mortality from breast cancer were decreasing in Hungary during the 
period 1998-2009 and a decreasing trend in mortality rates was found for malignant neoplasms 
of the uterus in Hungary between 1979 and 2013. However, the mortality rate for ovarian cancer 
did not decline during this period. In contrast, Kjaerbye-Thygesen et al [18] also reported a 
decrease of the age-standardized mortality rates of ovarian cancer from 10.8 to 9.0 per 100,000 
women per year in Denmark. 
Stålberg et al [19] found a 4.5-fold increased risk of mortality from ovarian cancer with 
exposure to infectious diseases from one to five years after diagnosis. Our findings support the 
environmental and infectious hazard in the etiology of death from cancer of the female genital 
organs and breast.  
The Hungarian mortality rates are high for breast cancer in spite of a nationwide screening 
program for breast and cervical cancer which was established in Hungary in 2001 and 2003, 
respectively [1]. However, the effectiveness of cervical cancer screening is similar to the reports 
from Belgium [20].  
August is a vacation period in Hungary and fewer medical staff are on duty which means 
that there is a heavier work load during this period. Thus, the "August-effect” could 
partly explain the higher mortality from genital organ cancer and breast cancer at the 
end of the summer [21-23]. Nevertheless, nosocomial infections could also increase the 
risk of the mortality among the immune deficient patients [24]. 
 
 
Conclusion  
The main finding of our study suggests that the infectious diseases may increase the risk of the 
mortality among the immune deficient patents. However, further investigations are needed to 
refine our hypothesis on the role of infections in the etiology of cancer mortality. 
To reduce the overall mortality rate in female genital organs and breast cancers and to prolong 
life expectancy, measures must be taken to reduce those mortality rates associated with seasonal 
differences. 
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Figure legends  
 
Figure 1. The age standardized female genital organs and breast cancer mortality rates in 
Hungary during the period 1979-2013. 
 
Figure 2. Significant seasonality was detected for overall deaths using Edwards’ method with 
a peak in January and a nadir in July. 
 
Figure 3. Seasonal variation in month of deaths from cancer of breast and female genital organs 
in Hungary during the period 1979-2013. 
 
Table headings 
Table 1. Total numbers of deaths by age during the 35 years of study in Hungary. 
Table 2. Age-standardized mortality rates per 100 000 persons 
Table 3. The monthly numbers of deaths used in seasonal analyses in Hungary during the period 
1979-2013. 
 
 
 
